BioSpace News Archive

Business

A New Environment for Repairing Eyes

UH Expert to Bring Consistency to Corneal Stem Cell Fate

November 12, 2018
·
3 min read
Deals

Takeda Sets a Date for Shareholders to Vote for the $62 Billion Acquisition of Shire

Pharma giant Takeda Pharmaceutical is looking to begin 2019 with a bang – closing its $62 billion acquisition of Shire plc by Jan. 8. This morning Takeda announced that it will hold an investor vote next month on the planned acquisition in order to swiftly move and finalize the deal.

November 12, 2018
·
3 min read
·
Alex Keown
Policy

Amarin Plans to Seek FDA Approval for CV Indication for Fish Oil Drug

Clinical data for a fish-oil-based drug from Amarin Corporation PLC confirmed the drug’s ability to reduce the relative risk reduction of adverse cardiovascular events by 25 percent, including a 20 percent reduction in cardiovascular death.

November 12, 2018
·
3 min read
·
Alex Keown
Deals

Well-Funded Unicorn Moderna Therapeutics Eyes $500 Million IPO

As a private company, Moderna has amassed a significant fortune of billions of dollars and a valuation of about $7 billion – all of this without any marketed product in the company’s field of messenger RNA (mRNA).

November 12, 2018
·
2 min read
·
Alex Keown
Policy

KEYTRUDA Snags Approval for Hepatocellular Carcinoma, Its 14th Approval Overall

On Friday, the FDA approved Merck’s Keytruda, an anti-PD-1 therapy, for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with the chemotherapy drug sorafenib.

November 12, 2018
·
2 min read
·
Alex Keown
As Deadliest Strain Ravages Country, Four Experimental Ebola Vaccines to Be Deployed in the Congo

As an outbreak of the Ebola virus in the Democratic Republic of the Congo worsens, a team of health officials has taken four experimental vaccines to the front lines and begun to administer it to patients who may have been exposed to the deadly virus.

November 12, 2018
·
3 min read
·
Alex Keown
Drug Development

Deep Dive: Immunovative Therapies’ Next-Generation Cancer Vaccine Could Change the Game

Checkpoint inhibitors are only effective against inflamed tumors, called ‘hot’ tumors. Unfortunately, most tumors are ‘cold’ (not inflamed) and hide from the immune system by appearing to be too similar to normal cells.

November 12, 2018
·
10 min read
·
Chelsea Weidman Burke
Career Advice

Resume Best Practices: 4 Things You Should Always Include in Your Employment History Section

Your employment or work history section of your resume is likely the single most important category in the entire document and, when done well, can make a powerful case to your potential employer about how and why you’re well qualified for their open position.

November 12, 2018
·
3 min read
·
Editorial Staff